Page last updated: 2024-10-31

nafamostat and Lymphohistiocytosis, Hemophagocytic

nafamostat has been researched along with Lymphohistiocytosis, Hemophagocytic in 1 studies

nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic

Lymphohistiocytosis, Hemophagocytic: A group of related disorders characterized by LYMPHOCYTOSIS; HISTIOCYTOSIS; and hemophagocytosis. The two major forms are familial and reactive.

Research Excerpts

ExcerptRelevanceReference
"She developed disseminated intravascular coagulation on the fourth day after admission."1.40Adult-onset Still's disease with disseminated intravascular coagulation and hemophagocytic syndrome: a case report. ( Kibata, M; Mimura, T; Shimodaira, M; Shirahata, K; Tsukadaira, A, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mimura, T1
Shimodaira, M1
Kibata, M1
Tsukadaira, A1
Shirahata, K1

Other Studies

1 other study available for nafamostat and Lymphohistiocytosis, Hemophagocytic

ArticleYear
Adult-onset Still's disease with disseminated intravascular coagulation and hemophagocytic syndrome: a case report.
    BMC research notes, 2014, Dec-22, Volume: 7

    Topics: Anti-Inflammatory Agents; Benzamidines; Disseminated Intravascular Coagulation; Female; Guanidines;

2014